Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for δ-opioid receptor subtypes in the rat

https://doi.org/10.1016/0014-2999(93)90230-FGet rights and content

Abstract

Intrathecally administered μ-opioid (morphine; DAMGO ([D-Ala2,N-MePhe4,Gly5-ol]enkephalin)) and δ-opioid (DPDPE ([D-Pen2,D-Pen5] enkephalin); DADLE ([D-Ala2,D-Leu5]enkephalin)) receptor preferring agonists were systematically challenged with the competitive opiate antagonists naloxone or naltrindole in the rat. Naloxone produced a dose-dependent reduction in agonist effect with the intrathecal IC50 being similar for all agonists (2.1–5.4 μg). In contrast, the naltrindole antagonist profile was (IC50 in μg) DPDPE (4.0); morphine (23.5); DADLE (> 30) and DAMGO (> 30). Three points are emphasized: (1) antagonism of DPDPE and not DAMGO by naltrindole suggests two distinct opioid sites; (2) a similar potency for naloxone against these agonists suggests that the agonists may act upon spinal sites for which naloxone has comparable affinity or that they may act upon separate sites which are functionally coupled and that the action of naloxone on one or the other site is responsible for the antagonism; and (3) given the modest cross-tolerance between DADLE and μ agonists, the failure of naltrindole to antagonize DADLE suggests that in the rat this peptide acts through a δ site different from that acted upon by DPDPE.

References (40)

  • A.S. Tung et al.

    In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord

    Brain Res.

    (1982)
  • T.L. Yaksh et al.

    Chronic catheterization of the spinal subarachnoid space

    Physiol. Behav.

    (1976)
  • E.J. Drower et al.

    Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penecillamine2-D-penecillamine5] enkephalin in the rat

    J. Pharmacol. Exp. Ther.

    (1991)
  • Q. Jiang et al.

    Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse

    J. Pharmacol. Exp. Ther.

    (1990)
  • Q. Jiang et al.

    Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: Selective actions at the deltanoncomplexed site

    J. Pharmacol. Exp. Ther.

    (1990)
  • Q. Jiang et al.

    Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltridonle 5′-isothiocyanate: Evidence for delta receptor subtypes

    J. Pharmacol. Exp. Ther.

    (1991)
  • H.W. Kosterlitz et al.

    Tyr-D-Ala-Gly-MePhe-NH(Ch2)2OH is a selective ligand for the mu opiate binding site

    Br. J. Pharmacol.

    (1981)
  • J.A.H. Lord et al.

    Endogenous opioid peptides: multiple agonists and receptors

    Nature (London)

    (1977)
  • A.B. Malmberg et al.

    Isobolographic and dose-response analysis of the interaction between mu and delta agonists: Effects of naltrindole and its benzofuran analog NTB

    J. Pharmacol. Exp. Ther.

    (1992)
  • W.R. Martin et al.

    The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog

    J. Pharmacol. Exp. Ther.

    (1976)
  • Cited by (0)

    1

    Present address: Pain Service, Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

    View full text